Initial pediatric subject shows sustained benefit with QRX003; second patient approved for full-body treatment in ongoing ...

Investing.com — Quoin制药有限公司（纳斯达克股票代码：QNRX），一家市值610万美元的专业制药公司，已为QRX003提交美国专利申请，这是一种针对罕见皮肤疾病（包括Netherton综合征（NS））的外用治疗药物。该公司股票在过去一年下跌超过65%，目前正在进行四项针对NS的临床试验，其中三项在美国食品药品监督管理局（FDA）的开放性研究性新药（IND）申请下进行。根据 ...

Target Indications Also Include Peeling Skin Syndrome, SAM Syndrome, Palmoplantar Keratoderma and Severe Atopic ...

The energy in the stadium was electric as the bulls raged out of the stall into the arena, throwing the riders off in mere ...

在其他近期新闻中，Quoin Pharmaceuticals ...

ASHBURN, Va., March 13, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan ...

Police in Du Quoin, Illinois are investigating a shooting, according to the mayor. On March 17 at around 9:15 p.m., Du Quoin Mayor Josh Downs posted to Facebook, stating there was a shooting at the ...

Quoin Pharmaceutical announced it has filed a U.S. patent application for novel topical formulations to treat a number of skin diseases, ...

Authorities are investigating a shooting that occurred Monday night at Casey’s General Store on North Hickory Street in Du Quoin.

Quoin Pharmaceuticals Ltd. has filed a U.S. patent application for new topical formulations aimed at treating several skin diseases, specifically Netherton Syndrome (NS) and Peeling Skin Syndrome.

An environmental group is pushing for a turtle rehabilitation and education centre to be built just south of Yeppoon as ...